+1.46%
Today
Loading 1D prices…
Company profile
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Suwanee, GA, United States
Employees
51
Fiscal year end
1231
CIK
1339005
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BEATHeartbeam Inc. Common Stock | $22.9M | $0.00 | — | -$0.62 | -0.98% | Buy |
| PLRZPolyrizon Ltd. Ordinary Shares | $26.2M | $0.00 | — | $4.90 | -1.78% | Unrated |
| MODDModular Medical Inc. Common Stock | $20.7M | $0.00 | — | -$12.36 | -3.79% | Unrated |
| RVPRetractable Technologies Inc. Common Stock | $20.4M | $38.3M | -32.84% | -$0.43 | -2.86% | Unrated |
| CTSOCytosorbents Corporation Common Stock | $20.2M | $37.1M | -22.12% | -$0.13 | +0.63% | Buy |